Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 2
2004 1
2006 1
2014 2
2015 3
2016 3
2017 4
2018 10
2019 6
2020 9
2021 13
2022 9
2023 12
2024 11
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.
Bisogno G, Minard-Colin V, Jenney M, Ferrari A, Chisholm J, Di Carlo D, Hjalgrim LL, Orbach D, Merks JHM, Casanova M. Bisogno G, et al. Among authors: hjalgrim ll. Cancers (Basel). 2023 Aug 7;15(15):4012. doi: 10.3390/cancers15154012. Cancers (Basel). 2023. PMID: 37568826 Free PMC article. Review.
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, Shipley J, van Rijn RR, de Vries I, van Ewijk R, de Keizer B, Gatz SA, Casanova M, Hjalgrim LL, Firth C, Wheatley K, Kearns P, Liu W, Kirkham A, Rees H, Bisogno G, Wasti A, Wakeling S, Heenen D, Tweddle DA, Merks JHM, Jenney M. Chisholm J, et al. Among authors: hjalgrim ll. Cancers (Basel). 2024 Feb 29;16(5):998. doi: 10.3390/cancers16050998. Cancers (Basel). 2024. PMID: 38473359 Free PMC article.
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH, Kluge R. Mauz-Körholz C, et al. Among authors: hjalgrim ll. Lancet Oncol. 2023 Mar;24(3):252-261. doi: 10.1016/S1470-2045(23)00019-0. Lancet Oncol. 2023. PMID: 36858722 Free article. Clinical Trial.
International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study.
Botta L, Didonè F, Lopez-Cortes A, Nieto AC, Desandes E, Hjalgrim LL, Jakab Z, Stiller CA, Zeller B, Gatta G, Pritchard-Jones K; BENCHISTA Project Working Group. Botta L, et al. Among authors: hjalgrim ll. Lancet Child Adolesc Health. 2025 Feb;9(2):89-99. doi: 10.1016/S2352-4642(24)00302-X. Lancet Child Adolesc Health. 2025. PMID: 39855760 Free article.
Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma.
van Gorp M, Grootenhuis MA, Darlington AS, Wakeling S, Jenney M, Merks JHM, Hjalgrim LL, Adams M. van Gorp M, et al. Among authors: hjalgrim ll. Cancers (Basel). 2023 Jan 9;15(2):420. doi: 10.3390/cancers15020420. Cancers (Basel). 2023. PMID: 36672371 Free PMC article.
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Mauz-Körholz C, et al. Among authors: hjalgrim ll. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 9. Lancet Oncol. 2022. PMID: 34895479 Free PMC article. Clinical Trial.
Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial.
Kurch L, Landman-Parker J, Georgi TW, Attarbaschi A, Balwierz W, Beishuizen A, Braun M, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Flerlage JE, Fosså A, Hjalgrim LL, Hraskova A, Karlén J, Klekawka T, Leblanc T, Montravers F, Lopci E, Mascarin M, Pears J, Pelz T, Prelog T, Rohde M, Sabri O, Steglich J, Stoevesandt D, Uytterbroeck A, Vordermark D, Wallace WH, Körholz D, Mauz-Körholz C, Kluge R, Hasenclever D. Kurch L, et al. Among authors: hjalgrim ll. J Nucl Med. 2025 Sep 2;66(9):1331-1337. doi: 10.2967/jnumed.125.269603. J Nucl Med. 2025. PMID: 40639904
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial.
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark D, Körholz D, Hasenclever D, Mauz-Körholz C. Daw S, et al. Among authors: hjalgrim ll. JAMA Oncol. 2025 Mar 1;11(3):258-267. doi: 10.1001/jamaoncol.2024.5636. JAMA Oncol. 2025. PMID: 39745682 Clinical Trial.
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia.
Stoltze U, Junk SV, Byrjalsen A, Cavé H, Cazzaniga G, Elitzur S, Fronkova E, Hjalgrim LL, Kuiper RP, Lundgren L, Mescher M, Mikkelsen T, Pastorczak A, Strullu M, Trka J, Wadt K, Izraeli S, Borkhardt A, Schmiegelow K. Stoltze U, et al. Among authors: hjalgrim ll. Leukemia. 2025 May;39(5):1031-1045. doi: 10.1038/s41375-025-02535-4. Epub 2025 Mar 24. Leukemia. 2025. PMID: 40128563 Review.
Childhood Cancer Predisposition and Evolutionary Constraints: Novel Lessons from Germline Genomes from 1,127 Children with Cancer.
Stoltze UK, Hansen TVO, Foss-Skiftesvik J, Byrjalsen A, Henriksen KA, Otamendi Laspiur A, Gerdes AM, Ostrowski SR, Sørensen E, Bak M, Lautrup CK, Grønskov K, Papaleo E, Hasle H, Mikkelsen TS, Wehner P, Saksager AB, Andersen MK, Kjærsgaard M, Hjortshøj TD, Frederiksen JH, Scheie D, Olsen TE, Tuckuviene R, Olsen M, Tümer Z, Mathiasen R, Brok J, Sehested A, Gorissen BL, Rasmussen S, Karczewski KJ, Hjalgrim LL, Wadt KAW, Schmiegelow K. Stoltze UK, et al. Among authors: hjalgrim ll. Clin Cancer Res. 2025 Nov 3;31(21):4495-4509. doi: 10.1158/1078-0432.CCR-25-0153. Clin Cancer Res. 2025. PMID: 40815213
87 results